Table 2. Frequency of Gln62Arg KLF11 in additional population samples.
OR (95% Cl), X2P value
|
|||||||
---|---|---|---|---|---|---|---|
Sample | NN | NM | MM | n | Minor allele frequency | Allele frequency | Dominant model |
Initial familial study | |||||||
Normoglycemic | 252 | 58 | 3 | 313 | 0.102 | 1.85(1.33-2.57) | 2.00(1.39-2.87) |
T2DM subjects | 211 | 95 | 7 | 313 | 0.174 | 0.00023 | 0.00019 |
Second set | |||||||
Normoglycemic | 1,138 | 307 | 18 | 1,463 | 0.117 | 1.18(1.01-1.38) | 1.18(1.00-1.40) |
T2DM subjects | 1,032 | 326 | 25 | 1,383 | 0.136 | 0.034 | 0.057 |
Overall | |||||||
Normoglycemic | 1,390 | 365 | 21 | 1,776 | 0.115 | 1.29(1.12-1.49) | 1.32(1.13-1.54) |
T2DM subjects | 1,243 | 421 | 32 | 1,696 | 0.143 | 0.00033* | 0.00054* |
NN, homozygous wild-type allele carriers; NM, heterozygous allele carriers; MM, homozygous mutant allele carriers; OR, odds ratio.
P value and combined OR for allelic effects calculated by a Mantel-Haenszel test (25).